Bavencio Approved for Rare Skin Cancer

THURSDAY, March 23, 2017 — Bavencio (avelumab) has been approved by the U.S. Food and Drug Administration to treat a rare but aggressive form of skin cancer called Merkel cell carcinoma (MCC), the agency said Thursday in a news release.
The drug,…
Source: Topamax